Mesenchymal stem cell-derived small extracellular vesicles promote mitochondrial repair of dopaminergic neurons via Homer protein homolog 3 in Parkinson's disease

  • Neural Regen Res. 2026 Jun 20. doi: 10.4103/NRR.NRR-D-25-01839.
Changlin Lian  1  2  3 Zhifeng Xu  4 Zi-Cong Wu  2  5 Xiao-Hui Deng  2  5 Dong-Xiao Lou  2  5 Zhong Pei  6 Qi Sun  2  5 Cheng-Lin Li  1 Lixin Pan  3 Yaoyuan Dong  7 Nan Ding  3 Guanghua Zhao  8 Yukai Wang  3 Qing-Ling Fu  2  5 Xin Li  1
Affiliations
  • 1. Department of Emergency Medicine, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong Province, China.
  • 2. Extracellular Vesicle Research and Clinical Translational Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • 3. Department of Neurology, First People's Hospital of Foshan, Foshan, Guangdong Province, China.
  • 4. Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • 5. Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • 6. Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
  • 7. Neurosurgery Center, Zhujiang Hospital Southern Medical University, Guangzhou, Guangdong Province, China.
  • 8. Department of Laboratory Medicine, First People's Hospital of Foshan, Foshan, Guangdong Province, China.
Abstract

Parkinson's disease is a major neurodegenerative disorder, and mitochondrial dysfunction has been increasingly recognized as a key contributor to its pathogenesis. Recent studies suggest that treatment with mesenchymal stem cell-derived small extracellular vesicles offers a promising cell-free strategy for mitigating neurodegeneration. In the present study, we investigated the effects of induced pluripotent stem cell-derived mesenchymal stem cell-derived small extracellular vesicles on dopaminergic neurons in a murine Parkinson's disease model and explored the underlying mechanisms related to mitochondrial impairment. A Parkinson's disease mouse model was established using 1-methyl-4-phenyl-1,2,4,5- tetrahydropyridine-induced neurotoxicity, followed by the intranasal administration of mesenchymal stem cell-derived small extracellular vesicles and comprehensive behavioral and pathological assessments. To elucidate the mechanistic basis of any effects, we examined mitochondrial function and Homer protein homolog 3 (Homer3) expression in brain tissue. Mice with Homer3 knockdown were used to validate the role of Homer3 in the therapeutic effects of mesenchymal stem cell-derived small extracellular vesicles. Mesenchymal stem cell-derived small extracellular vesicle administration significantly reduced motor dysfunction in 1-methyl-4-phenyl-1,2,4,5-tetrahydropyridine-induced Parkinson's disease mice by protecting dopaminergic neurons. Furthermore, mesenchymal stem cell-derived small extracellular vesicles increased both mitochondrial number and function through Homer3 upregulation in Parkinson's disease mice. The therapeutic benefits of mesenchymal stem cell-derived small extracellular vesicles in rescuing dopaminergic neurons were impaired by Homer3 knockdown. Collectively, these findings suggest that, at least in part, mesenchymal stem cell-derived small extracellular vesicles ameliorate dopaminergic neuron damage via the Homer3-mediated restoration of mitochondrial function in a mouse model of Parkinson's disease. Our results highlight the neuroprotective role of mesenchymal stem cell- derived small extracellular vesicles in Parkinson's disease and provide new perspectives on their therapeutic potential.

Keywords
1-methyl-4-phenyl-1,2,4,5-tetrahydropyridine; Homer3; Parkinson's disease; dopaminergic neurons; exosomes; extracellular vesicles; mesenchymal stem cells; mitochondrial dysfunction; neurodegeneration; neuroprotection.
Products